Gevo insider plans sale of 31,096 common shares

Gevo, Inc. insider Paul Bloom filed to potentially sell common stock.

Rhea-AI Filing Summary

Gevo, Inc. insider Paul Bloom filed to potentially sell common stock. The notice covers a proposed sale of 31,096 shares of Gevo common stock through Stifel Nicolaus & Company Inc. on Nasdaq, with an aggregate market value of $48,068.20, with a proposed sale date of August 6, 2026.

The shares relate to 69,074 restricted stock awards granted on August 3, 2023 as equity compensation from the issuer. The filing also lists prior sales in the last three months: 78,735 shares of common stock sold on May 27, 2026 for $138,558.00, and 35,189 shares sold on June 12, 2026 for $50,151.00.

Key Figures

Shares proposed for sale: 31,096 shares Aggregate market value of proposed sale: $48,068.20 Restricted stock awards related to sale: 69,074 shares +3 more

6 metrics

Shares proposed for sale 31,096 shares Common stock to be sold through Stifel Nicolaus & Company Inc. on Nasdaq

Aggregate market value of proposed sale $48,068.20 Value associated with the 31,096 shares of common stock

Restricted stock awards related to sale 69,074 shares Shares from restricted stock awards granted on August 3, 2023 as equity compensation

Prior sale on May 27, 2026 78,735 shares for $138,558.00 Common stock sold during the past three months

Prior sale on June 12, 2026 35,189 shares for $50,151.00 Common stock sold during the past three months

Proposed sale date August 6, 2026 Date associated with the planned sale of 31,096 shares

Key Terms

Restricted Stock Awards, Equity Compensation, Form 144

3 terms

Restricted Stock Awards financial

"Common Stock | 08/03/2023 | Restricted Stock Awards | Issuer"

Restricted stock awards are company shares given to employees or executives that cannot be sold or transferred until certain conditions — like staying with the company for a set time or meeting performance targets — are met, like a gift that is locked in a safe until rules are satisfied. Investors care because these awards tie management’s pay to company performance, can increase the number of shares outstanding when they become tradable (dilution), and may signal expected future selling pressure or commitment to long-term growth.

Equity Compensation financial

"69074 | 08/06/2026 | Equity Compensation"

Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

Form 144 regulatory

"144: Securities Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Gevo (GEVO) insider Paul Bloom plan to sell under this Form 144?

Paul Bloom filed to potentially sell 31,096 shares of Gevo common stock through Stifel Nicolaus & Company Inc., with an indicated aggregate market value of $48,068.20 and a proposed sale date of August 6, 2026.

What is the source of the Gevo (GEVO) shares covered in this Form 144?

The shares relate to restricted stock awards granted on August 3, 2023 as equity compensation from Gevo, Inc., covering a total of 69,074 common shares associated with the compensation grant.

Which broker is handling the planned Gevo (GEVO) stock sale for Paul Bloom?

The proposed sale of Gevo common stock is listed as being handled by Stifel Nicolaus & Company Inc., located at 501 N Broadway, St. Louis, MO 63102, with trading indicated on Nasdaq.

What prior Gevo (GEVO) stock sales by Paul Bloom are disclosed in the last three months?

The filing lists two prior sales: 78,735 shares sold on May 27, 2026 for $138,558.00, and 35,189 shares sold on June 12, 2026 for $50,151.00, both in Gevo common stock.

On which market will the Gevo (GEVO) shares in this Form 144 be sold?

The proposed sale of 31,096 Gevo common shares is indicated for trading on Nasdaq, with Stifel Nicolaus & Company Inc. listed as the broker handling the transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/06/2026 - 04:33 PM Accepted by SEC EDGAR 08/06/2026 - 04:32 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001854032
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Gevo, Inc.
SEC File Number	001-35073
Address of Issuer	345 INVERNESS DRIVE SOUTH, BUILDING C Suite 310 ENGLEWOOD COLORADO 80112
Phone	303-858-8358
Name of Person for Whose Account the Securities are To Be Sold	Bloom Paul D
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Stifel Nicolaus & Company Inc 501 N Broadway St. Louis MO 63102	31096	48068.20	243411329	08/06/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	08/03/2023	Restricted Stock Awards	Issuer			69074	08/06/2026	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Paul Bloom 345 INVERNESS DRIVE SOUTH BUILDING C SUITE 310 ENGLEWOOD CO 80112	Common Stock	05/27/2026	78735	138558.00
Paul Bloom 345 INVERNESS DRIVE SOUTH BUILDING C SUITE 310 ENGLEWOOD CO 80112	Common Stock	06/12/2026	35189	50151.00

144: Remarks and Signature

Remarks
Date of Notice	08/06/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/22/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ James Weimer, as a duly authorized representative of STIFEL, as attorney-in-fact for Paul Bloom
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)